Inflammatory markers and the risk of coronary heart disease in men and women.

  title={Inflammatory markers and the risk of coronary heart disease in men and women.},
  author={Jennifer Pai and Tobias Pischon and Jing Ma and JoAnn E. Manson and Susan E Hankinson and Kaumudi J. Joshipura and Gary C Curhan and Nader Rifai and Carolyn C Cannuscio and Meir J. Stampfer and Eric B. Rimm},
  journal={The New England journal of medicine},
  volume={351 25},
BACKGROUND Few studies have simultaneously investigated the role of soluble tumor necrosis factor alpha (TNF-alpha) receptors types 1 and 2 (sTNF-R1 and sTNF-R2), C-reactive protein, and interleukin-6 as predictors of cardiovascular events. The value of these inflammatory markers as independent predictors remains controversial. METHODS We examined plasma levels of sTNF-R1, sTNF-R2, interleukin-6, and C-reactive protein as markers of risk for coronary heart disease among women participating in… 

Figures and Tables from this paper

C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.

CRP and TNFalpha were significant, independent predictors of CHD and CVD events and total mortality among men, providing further support to the important role of inflammation in the pathogenesis of CVD.

A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease.

Findings suggest there are rapid consequences of smoking cessation on inflammatory biomarkers in women at risk for CVD and additional, larger studies are required to confirm changes in "measurable milestones" that could serve as motivating factors to assist smokers to quit.

C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression.

Plasma Cytokines, Metabolic Syndrome, and Atherosclerosis in Humans

Plasma IL-6 and sol-TNFR2 levels were independently associated with CAC, suggesting a role in integrating innate immune and adipose signaling in promoting atherosclerosis and cardiovascular risk.

C-Reactive Protein (CRP) Gene Polymorphisms, CRP Levels, and Risk of Incident Coronary Heart Disease in Two Nested Case-Control Studies

Common variation in the CRP gene was significantly associated with plasma CRP levels; however, the association between common SNPs andCRP levels did not correspond to a predicted change in CHD risk.


Results suggest a moderate positive association of MMP-9 with coronary heart disease (CHD) risk, while serum sCD40L may be moderately inversely related to CHD risk, and the need for further research into novel inflammatory markers of CVD risk.

Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review

Long-term IL-6 levels are associated with CHD risk about as strongly as are some major established risk factors, but causality remains uncertain, highlighting the potential relevance of IL- 6–mediated pathways to CHD.



C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.

Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study

A composite summary indicator of inflammation showed a strong association with incident cardiovascular events, with an especially high risk if all 3 inflammatory markers were in the highest tertile.

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

Findings suggest that some inflammatory processes, unrelated to the chronic infections studied here, are likely to be involved in coronary heart disease.

The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.

Measurement of CRP in elderly people has no additional value in coronary disease risk prediction when traditional cardiovascular risk factors are known.

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

These prospective findings indicate that CRP and IL-6 independently predict vascular events among apparently healthy postmenopausal women and that HRT increases CRP.

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

A role for cytokine-mediated inflammation in the early stages of atherogenesis is supported in apparently healthy men, and elevated levels of IL-6 are associated with increased risk of future MI.

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

The long-term stability of C-reactive protein values was similar to that of both blood pressure and total serum cholesterol, and recommendations regarding its use in predicting the likelihood of coronary heart disease may need to be reviewed.

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Elevated levels of CRP and IL-6 predict the development of type 2 DM, and data support a possible role for inflammation in diabetogenesis.

Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

Elevated levels of lipoprotein-associated phospholipase A2 appear to be a strong risk factor for coronary heart disease, a finding that has implications for atherogenesis and the assessment of risk.